Peptide Therapeutics Gain Traction in Treating Various Metabolic Disorders
Amylin is a Peptide Therapeutics In Metabolic Disorders co-secreted with insulin from pancreatic beta cells. Pramlintide (Symlin) is an amylin mimetic used along with mealtime insulin injections to help control postprandial blood glucose in type 1 and type 2 diabetics. It suppresses glucagon secretion and slows gastric emptying to complement insulin action.
Peptides are short chains of amino acids linked by peptide (amide) bonds. They differ from proteins in size as proteins are much larger biomolecules composed of one or more chains of amino acids.

Peptide Therapeutics In Metabolic Disorders Market

https://www.coherentmarket...

#PeptideTherapeutics , #MetabolicDisorders , #BiotechInnovation , #DiabetesTreatment ,
#NextGenMedicine , #PrecisionTherapeutics , #CoherentMarketInsights .